AN2 Therapeutics
ANTX
ANTX
45 hedge funds and large institutions have $41.7M invested in AN2 Therapeutics in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.55M | |
| 2 | +$1.5M | |
| 3 | +$923K | |
| 4 |
Goldman Sachs
New York
|
+$421K |
| 5 |
Two Sigma Advisers
New York
|
+$290K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$3.74M | |
| 3 | -$369K | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$248K |
| 5 |
Jane Street
New York
|
-$192K |